Viewing data from:

LISDEXAMFETAMINE DIMESYLATE

ANDA

LISDEXAMFETAMINE DIMESYLATE | A214134 | SUN PHARMACEUTICAL INDUSTRIES INC

6 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: VYVANSE(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 6 NDCs

Highest NADAC/Unit

$4.39

per ea

Lowest NADAC/Unit

$3.36

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
57664008488LISDEXAMFETAMINE 20 MG TB CHEW	$4.39	EA	Generic	—	2026-08-19
57664008688LISDEXAMFETAMINE 40 MG TB CHEW	$3.72	EA	Generic	—	2026-08-19
57664008388LISDEXAMFETAMINE 10 MG TB CHEW	$3.59	EA	Generic	—	2026-08-19
57664008788LISDEXAMFETAMINE 50 MG TB CHEW	$3.57	EA	Generic	—	2026-08-19
57664008888LISDEXAMFETAMINE 60 MG TB CHEW	$3.51	EA	Generic	—	2026-08-19
57664008588LISDEXAMFETAMINE 30 MG TB CHEW	$3.36	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain9 active DMFs1 inactive

8 active API suppliers hold Drug Master Files for this ingredient.

VERANOVA LPLISDEXAMFETAMINE DIMESYLATE

DMF 224422009

CHATTEM CHEMICALS INCLISDEXAMFETAMINE DIMESYLATE

DMF 322892018

SPECGX LLCLISDEXAMFETAMINE DIMESYLATE

DMF 348232020

NORAMCO LLCLISDEXAMFETAMINE DIMESYLATE DRUG SUBSTANCE

DMF 356452021

AUGUST PHARMACEUTICALS LLCLISDEXAMFETAMINE DIMESYLATE INT

DMF 357542021

ALKEM LABORATORIES LTDLISDEXAMFETAMINE DIMESYLATE

DMF 386672023

VERANOVA LPLISDEXAMFETAMINE DIMESYLATE B1625

DMF 388742023

GRANULES INDIA LTDLISDEXAMFETAMINE DIMESYLATE

DMF 417372025

COHANCE LIFESCIENCES LTDLISDEXAMFETAMINE

DMF 422822025

SPECGX LLCInactiveLISDEXAMFETAMINE DIMESYLATE

DMF 322102017

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.